App-Quantinova.ai

APHAERETIC PROCEDURES AND INTRAVENOUS IMMUNOGLOBULINS IN ADDITION TO CONVENTIONAL THERAPY TO TREAT PREGNANT WOMEN WITH HIGH-RISK ANTIPHOSPHOLIPID ANTIBODY SYNDROME. A PROSPECTIVE COHORT STUDY

A. Ruffatti - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Aspirin

BENEFICIAL EFFECTS OF IN VIVO UBIQUINOL SUPPLEMENTATION ON ATHERO-THROMBOSIS PREVENTION IN ANTIPHOSPHOLIPID SYNDROME PATIENTS. PRELIMINARY RESULTS OF A CLINICAL TRIAL

C. Lopez-Pedrera - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

CoQ10

RESPONSE TO ECULIZUMAB IN THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME

E. Zapantis - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Eculizumab

THE EFFICACY OF RITUXIMAB FOR REFRACTORY THROMBOTIC MICROANGIOPATHY (TMA) ASSOCIATED WITH CONNECTIVE TISSUE DISEASES REGARDLESS OF ADAMTS-13 ACTIVITY LEVELS

Y. Takeuchi - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Rituximab

SPLENECTOMY IN SYSTEMIC LUPUS ERYTHEMATOSUS VERSUS AUTOIMMUNE HEMATOLOGICAL DISEASES: TO LATE OR TO EARLY?

G.N. Barron - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

ASSOCIATION BETWEEN SPONDYLOARTHRITIS AND TAKAYASU ARTERITIS: A STUDY OF 14 CASES

E. Riviere - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Adalimumab

ROLE OF LEUKOCYTE SUBSETS IN THE INFLAMMATION, OXIDATIVE STRESS AND BONE TURNOVER IN ANKYLOSING SPONDYLITIS PATIENTS

Y. Jimenez-Gomez - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitric oxide

BRONCHIAL ARTERY ENLARGEMENT MAY BE THE CAUSE OF RECURRING HEMOPTYSIS IN BEHCE-S SYNDROME PATIENTS WITH PULMONARY ARTERY INVOLVEMENT DESPITE TREATMENT RESPONSE

V. Hamuryudan - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Cyclophosphamide

VENOUS THROMBOEMBOLIC EVENTS AND CEREBROVASCULAR ACCIDENT IN PATIENTS WITH GIANT CELL ARTERITIS: A POPULATION BASED RETROSPECTIVE COHORT STUDY

A. Lo Gullo - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

RELAPSE RATES AND CHARACTERISTICS IN BIOPSY-PROVEN GIANT CELL ARTERITIS: A SINGLE-INSTITUTION COHORT STUDY

C. Labarca - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Glucocorticoid

PREDICTORS OF QUALITY OF LIFE IN BEHCE-S SYNDROME

S. Bozcan - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Venous thrombosis

N/A

VITAMIN B12, HOMOCYSTEINE AND METHYLMALONIC ACID LEVELS IN PATIENTS WITH NEURO-BEHCE-S SYNDROME

B. Bitik - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Cyanocobalamin

NEUTROPHIL/LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN BEHCE-S DISEASE

A. Balkarli - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Thrombomodulin alfa

A VERY HIGH PREVALANCE OF AVASCULAR NECROSIS IN TURKISH PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS (WEGENE-S): PRELIMINARY RESULTS FROM A SINGLE CENTRE

B. Toz - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Glucocorticoid

VEINS THROMBOSIS OCCURING IN TAKAYASU ARTERITIS: CAUSAL OR CASUAL RELATION?

H. Maamouri - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

BEHCET DISEASE FREQUENCY AMONG PEOPLE WITH VISUAL LOSS

O. Uyaroglu - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Venous thrombosis

N/A

CHARACTERISTICS OF NEUROLOGICAL MANIFESTATIONS OF BEHCE-S DISEASE: ABOUT 60 CASES

N. Boughanmi - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

WHAT IS NEW IN BEHCE-S SYNDROME?

H. Yazici - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Apremilast

THROMBOEMBOLISM IN RHEUMATOLOGY: INVESTIGATION OF THE RISKS OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN INFLAMMATORY ARTHRITIS, CONNECTIVE TISSUE DISEASES, VASCULITIS AND MYOSITIS

J. E. Pope - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Venous thrombosis

N/A

REGULATORY T CELLS IN PERIPHERAL BLOOD OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

N. Soroka - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Filters

7277 Abstracts